Royston Ivor

CIK 0001026765

CEO & PresidentDirector

Filings

Latest Nov 27, 2024

Issuers covered

Showing

13 of 13

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Royston Ivor. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Royston Ivor has filed

Ticker	Issuer	Filings	Last filed
VIRX	Viracta Therapeutics, Inc.	13	Nov 27, 2024

13 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Nov 27, 2024	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
Sep 12, 2024	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
Jun 24, 2024	VIRXViracta Therapeutics, Inc.	Holdings only	-	-	-
May 29, 2024	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
Feb 27, 2024	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
Nov 28, 2023	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
Aug 29, 2023	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
Jun 9, 2023	VIRXViracta Therapeutics, Inc.	Holdings only	-	-	-
May 26, 2023	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
Feb 28, 2023	VIRXViracta Therapeutics, Inc.	MExercise	25,219	$0.00	$0
May 27, 2022	VIRXViracta Therapeutics, Inc.	SSale	13,162	$1.9011	$25,022
Mar 18, 2022	VIRXViracta Therapeutics, Inc.	Holdings only	-	-	-
Mar 1, 2022	VIRXViracta Therapeutics, Inc.	SSale	14,635	$2.7795	$40,678

Showing 1-13 of 13

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.